One Post Street
322 articles with McKesson
McKesson Corporation announced that the McKesson board of directors has elected Linda Mantia as an independent director and member of the board’s Audit and Governance Committees, effective Oct. 19, 2020.
McKesson Ventures, the venture capital arm of McKesson Corporation, announces the expansion of its leadership team, promoting Jennifer Carter and Carrie Hurwitz Williams to partners of McKesson Ventures.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 17, 2020.
McKesson Corporation announced the appointment of Rebecca McKillican as Chief Executive Officer, McKesson Canada effective immediately.
Increased fiscal 2021 Adjusted Earnings per diluted share guidance range to $14.70 to $15.50, from the previous range of $13.95 to $14.75.
McKesson announced that The Disability Equality Index has named the company as one of its 2020 Best Places to Work for Disability Inclusion with a top-ranking score of 100.
McKesson Realigns Organizational Structure to Better Serve Customers and Patients While Optimizing Growth
McKesson Corporation announces changes to its reportable business structure.
McKesson Corporation reported results for the fourth quarter and fiscal year ended March 31, 2020.
McKesson Appoints Lyn Fitzgerald as Vice President of Sales for McKesson Data, Evidence & Insights
Industry veteran joins McKesson after more than 13 years at National Comprehensive Cancer Network
The Board of Directors of McKesson Corporation declared a regular dividend of 41 cents per share of common stock.
McKesson Corporation will release its fourth quarter fiscal 2020 financial results before market open on Wednesday, May 20, 2020.
McKesson Corporation announced it is updating its adjusted earnings outlook for the fiscal year ending March 31, 2020 to reflect the completion of the company’s exit of its investment in Change Healthcare, as announced on March 10, 2020.
McKesson Corporation announced the final exchange ratio of 11.4086-for-one in connection with its previously announced offer to its stockholders to exchange their shares of McKesson common stock for shares of PF2 SpinCo, Inc. common stock.
The Board of Directors of McKesson Corporation yesterday declared a regular dividend of 41 cents per share of common stock.
McKesson to Present at the 38th Annual J.P. Morgan Healthcare Conference: Will Provide Company Overview and Review Updated Financial Outlook
Brian Tyler, chief executive officer of McKesson, will provide a company overview and review topics including:
New entity combines wholesale operations to drive sustainable growth and deliver efficient distribution solutions for an evolving market
McKesson Appoints Nancy Flores as Executive Vice President, Chief Information and Chief Technology Officer
Flores to succeed Kathy McElligott who is retiring February 3, 2020
Health system pharmacy experts stress partnerships and proactive use of data moving forward
11/27/2019The companies are facing questions in a criminal probe regarding their marketing distribution practices related to the sale of opioids.
McKesson Corporation reported results for the second quarter ended September 30, 2019.